Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Mol Med Rep ; 16(3): 2707-2713, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28713939

ABSTRACT

The aim of the present study was to identify key genes that may be involved in the pathogenesis of Tetralogy of Fallot (TOF) using bioinformatics methods. The GSE26125 microarray dataset, which includes cardiovascular tissue samples derived from 16 children with TOF and five healthy age­matched control infants, was downloaded from the Gene Expression Omnibus database. Differential expression analysis was performed between TOF and control samples to identify differentially expressed genes (DEGs) using Student's t­test, and the R/limma package, with a log2 fold­change of >2 and a false discovery rate of <0.01 set as thresholds. The biological functions of DEGs were analyzed using the ToppGene database. The ReactomeFIViz application was used to construct functional interaction (FI) networks, and the genes in each module were subjected to pathway enrichment analysis. The iRegulon plugin was used to identify transcription factors predicted to regulate the DEGs in the FI network, and the gene­transcription factor pairs were then visualized using Cytoscape software. A total of 878 DEGs were identified, including 848 upregulated genes and 30 downregulated genes. The gene FI network contained seven function modules, which were all comprised of upregulated genes. Genes enriched in Module 1 were enriched in the following three neurological disorder­associated signaling pathways: Parkinson's disease, Alzheimer's disease and Huntington's disease. Genes in Modules 0, 3 and 5 were dominantly enriched in pathways associated with ribosomes and protein translation. The Xbox binding protein 1 transcription factor was demonstrated to be involved in the regulation of genes encoding the subunits of cytoplasmic and mitochondrial ribosomes, as well as genes involved in neurodegenerative disorders. Therefore, dysfunction of genes involved in signaling pathways associated with neurodegenerative disorders, ribosome function and protein translation may contribute to the pathogenesis of TOF.


Subject(s)
Gene Regulatory Networks , Genomics/methods , Tetralogy of Fallot/genetics , Child , Databases, Genetic , Gene Expression Profiling/methods , Humans , Infant , Microarray Analysis/methods , Protein Interaction Maps , Signal Transduction , Software , Tetralogy of Fallot/metabolism
2.
Zhonghua Shao Shang Za Zhi ; 29(4): 371-4, 2013 Aug.
Article in Chinese | MEDLINE | ID: mdl-24351537

ABSTRACT

Hydrofluoric acid (HF) is one of the most common inorganic acids used widely in industrial circle. HF not only causes cutaneous burn, but also induces systemic toxicity by its unique injury mechanism. Accurate and timely diagnosis and treatment are critical after HF burns. To date, the strategies for treating HF burns have been developed, mainly including topical treatments and systematic support. However, there is no standard treatment strategy with wide acceptance in the world. This paper presents a comprehensive overview of the advances in the research of strategies for the treatment of HF burns.


Subject(s)
Burns, Chemical/therapy , Hydrofluoric Acid , Humans
3.
Zhonghua Gan Zang Bing Za Zhi ; 21(9): 679-83, 2013 Sep.
Article in Chinese | MEDLINE | ID: mdl-24160343

ABSTRACT

OBJECTIVE: To study the relationship between metastasis or recurrence of hepatocellular carcinoma (HCC) and hepatitis B virus (HBV) DNA load or the presence of double mutation at 1762/1764 in the basic core promoter (BCP). METHODS: One-hundred-and-fifty-seven patients with HCC were included in the study. Events of tumor metastasis or recurrence were recorded during 120 weeks of clinical follow-up after treatment by surgery or transarterial chemoembolization (TACE). The 1-year follow-up included monthly alpha fetoprotein (AFP) measurement and abdominal ultrasonography (US), as well as helical computed tomographic (CT) scan performed every 3 months. Follow-up beyond 1-year (surveillance) included AFP measurement and abdominal US every 2 months and helical CT scan every 6 months. Suspected metastasis or recurrence was investigated by hepatic angiography and confirmed according to the combined imaging findings. Serum HBV DNA level was measured by real-time PCR. HBV genotypes were determined by PCR-restriction fragment length polymorphism analysis. RESULTS: Of the 157 HCC cases 110 experienced tumor metastasis or recurrence; the cumulative probability of post-treatment HCC metastasis or recurrence was 4 (2.55%) at week 12, 14 (8.92%) at week 24, 28 (17.83%) at week 48, 64 (40.76%) at week 72, 92 (58.60%) at week 96, and 110 (70.06%) at week 120. Multivariate analysis indicated that both the BCP 1762/1764 double mutations and HBV DNA levels were risk factors for HCC recurrence or metastasis. In particular, the incidence of HCC recurrence or metastasis increased with baseline serum HBV DNA levels in a dose-response manner, ranging from 8/19 (42.1%) for less than 3 log10 copies/ml HBV DNA to 35/61 (57.3%) for 3-5 log10 copies/ml and 67/77 (87.0%) for more than 5 log10 copies/ml. After adjusting for potential confounders, serum HBV DNA level remained independently associated with HCC metastasis or recurrence. HCC recurrence or metastasis occurred in 22/43 (51.2%) of patients without BCP 1762/1764 mutations and 88/114 (77.2%) of patients with BCP 1762/1764 mutations. The adjusted odds ratio for patients infected with BCP 1762/1764 double mutation HBV, compared with those infected with non-BCP 1762/1764 mutation HBV, was 5.264 (95% CI: 1.436-12.574, P less than 0.05). CONCLUSION: Infection with HBV carrying the BCP 1762/1764 double mutation and presence of high HBV DNA load are independent risk factors for developing HCC metastasis or recurrence after surgery or TACE.


Subject(s)
Carcinoma, Hepatocellular/pathology , Hepatitis B virus/genetics , Liver Neoplasms/pathology , Mutation , Adult , Aged , Carcinoma, Hepatocellular/virology , DNA, Viral/blood , Female , Genotype , Hepatitis B Core Antigens/genetics , Humans , Liver Neoplasms/virology , Male , Middle Aged , Neoplasm Metastasis , Neoplasm Recurrence, Local , Promoter Regions, Genetic , Viral Load
4.
Zhonghua Er Ke Za Zhi ; 50(9): 689-91, 2012 Sep.
Article in Chinese | MEDLINE | ID: mdl-23158820

ABSTRACT

OBJECTIVE: To observe the expression of urotensin II (UII) on the lung of patients with pulmonary hypertension (PH) with congenital heart disease and investigate the meaning of this phenomenon. METHOD: Thirty eight patients with CHD were divided into three groups according to pulmonary arterial systolic pressure (PASP) measured in cardiac catheterization and surgery: normal pulmonary pressure group (N group, PASP < 30 mm Hg, n = 10), mild PH group (M group, PASP ≥ 30 mm Hg, n = 15), severe or moderate PH group (S group, PASP ≥ 50 mm Hg, n = 13). The expression of UII protein and UII mRNA in pulmonary arterioles were measured separately by immunohistochemical (IHC) analysis and in situ hybridization (ISH) analysis. RESULT: (1) The results of UIIIHC staining: The UII protein expression of group M was higher than that of group N (20.22 ± 3.58 vs. 14.34 ± 2.18, P < 0.01), but less than group S (20.22 ± 3.58 vs. 28.92 ± 3.22, P < 0.05). (2) The results of UIIISH mRNA staining were similar to IHC staining, the A value of group M was higher than group N (12.51 ± 2.02 vs. 8.85 ± 1.41, P < 0.05), less than that of group S(12.51 ± 2.02 vs. 25.35 ± 4.33, P < 0.01). (3) Correlation study: there was a positive correlation between the A values of UIIIHC and pulmonary hypertension (r = 0.64, P < 0.01, n = 38), a positive correlation between the A values of UIIISH and pulmonary hypertension (r = 0.58, P < 0.01, n = 38). CONCLUSION: There was the expression of Urotensin II protein and mRNA in the lung of pulmonary hypertension patients with congenital heart disease, and these expression may involve the formation of pulmonary hypertension of congenital heart disease.


Subject(s)
Heart Defects, Congenital/metabolism , Hypertension, Pulmonary/metabolism , Lung/metabolism , Urotensins/metabolism , Adolescent , Blood Pressure , Case-Control Studies , Child , Child, Preschool , Female , Heart Defects, Congenital/complications , Heart Defects, Congenital/physiopathology , Humans , Hypertension, Pulmonary/etiology , Hypertension, Pulmonary/physiopathology , Immunohistochemistry , In Situ Hybridization , Infant , Lung/physiopathology , Male , Pulmonary Artery/metabolism , Pulmonary Artery/physiopathology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Severity of Illness Index , Urotensins/genetics
5.
Zhongguo Dang Dai Er Ke Za Zhi ; 14(9): 664-6, 2012 Sep.
Article in Chinese | MEDLINE | ID: mdl-22989434

ABSTRACT

OBJECTIVE: To investigate the early predictive indices of critical condition in infants and young children with severe pneumonia, and to provide reference for diagnosis and treatment of the disease. METHODS: Clinical data were collected on 411 patients (aged 1-36 months) with severe pneumonia who were admitted from January 2009 to December 2011, and multivariate logistic regression analysis was performed using 23 potential indices. These cases were divided into a critical group of 139 cases who died in hospital or needed rescue or mechanical ventilation during the course of disease and an ordinary group of 411 cases. RESULTS: Eight indices with statistical significance were selected to predict the critical condition after multivariate logistic regression analysis, including hypocalcemia with the highest odds ratio (OR) (11.488), followed by sinus tachycardia (7.506), congenital heart disease (5.977), brain disorder symptoms (5.182), premature birth (4.978), blood potassium abnormality (2.910), metabolic acidosis (2.489) and malnutrition (2.048). CONCLUSIONS: The predictive indices of critical condition in infants and young children with severe pneumonia are hypocalcemia, sinus tachycardia, congenital heart disease, brain disorder symptoms, premature birth, blood potassium abnormality, metabolic acidosis and malnutrition. The infants and young children with these risk factors need intensive care.


Subject(s)
Pneumonia/complications , Calcium/metabolism , Child, Preschool , Female , Humans , Infant , Logistic Models , Male
8.
Zhongguo Dang Dai Er Ke Za Zhi ; 12(9): 744-8, 2010 Sep.
Article in Chinese | MEDLINE | ID: mdl-20849728

ABSTRACT

OBJECTIVE: Previous studies have shown that hydrogen sulfide (H2S) plays key roles in a number of biological processes, including vasorelaxation, inflammation, apoptosis, ischemia/reperfusion and oxidative stress, which are involved in the pathogenesis of myocarditis. This study aimed to examine the expression of cystathionine-γ-lyase(CSE)/H2S pathway in mice with viral myocarditis. METHODS: Six-week-old inbred male mice were randomly assigned to control (n=25) and myocarditis group (n=30). The myocarditis and the control groups were inoculated intraperitoneally with 0.1 mL 10-5.69TCID50/mL CVB3 or vehicle (PBS) alone respectively. Ten mice were sacrificed 4 and 10 days after injection. Blood and heart specimens were harvested for measuring the content of serum H2S and the H2S production rates in cardiac tissues. Heart sections were stained with hematoxylin and eosin. Immunohistochemisty was used to detect the CSE protein expression in the heart. RESULTS: In the myocarditis group, the serum H2S content and H2S production rates in cardiac tissues were significantly higher than those in the control group 4 and 10 days after injection (P<0.05). The expression of CSE protein in the heart in the myocarditis group was also significantly higher than that in the control group (P<0.05). CONCLUSIONS: CSE and its downstream production H2S increase in mice with acute viral myocarditis. The increased expression of CSE/H2S pathway might be involved in the pathogenesis of viral myocarditis.


Subject(s)
Coxsackievirus Infections/etiology , Cystathionine gamma-Lyase/analysis , Enterovirus B, Human , Hydrogen Sulfide/metabolism , Myocarditis/etiology , Animals , Extracellular Signal-Regulated MAP Kinases/metabolism , Killer Cells, Natural/immunology , Male , Mice , Mice, Inbred BALB C
9.
Zhongguo Dang Dai Er Ke Za Zhi ; 11(10): 802-4, 2009 Oct.
Article in Chinese | MEDLINE | ID: mdl-19849936

ABSTRACT

OBJECTIVE: To study the changes of serum leptin (LEP) and vascular endothelial growth factor (VEGF) in children with congenital heart disease(CHD) and their roles in CHD. METHODS: Forty-eight children with acyanotic CHD (ACHD group), 20 age-matched children with cyanotic CHD (CCHD group) and 20 healthy children (control group) were enrolled. The ACHD group was subdivided into two groups with (n=20) or without concurrent heart failure (n=28). Serum LEP, VEGF, total protein and albumin levels and body mass index (BMI) were measured. RESULTS: Serum total protein and albumin levels were not apparently different in all CHD children from healthy controls, but there was a significant difference in the BMI between them (p<0.01). Serum LEP and VEGF levels and the ratio of LEP/BMI in all CHD children were significantly higher than those in healthy controls (p<0.01). Compared with the ACHD group without heart failure, the serum LEP and VEGF levels and the ratio of LEP/BMI in the CCHD and the ACHD with heart failure groups increased significantly (p<0.01). In the ACHD group, serum LEP level was positively correlated with BMI (p<0.01). In the CCHD group, there were positive correlations between serum LEP level and serum VEGF level (p<0.01) and between hemoglobin concentration and serum VEGF level (p<0.01). Arterial oxygen saturation was negatively correlated with serum VEGF (p<0.01) and LEP levels (p<0.01) in the CCHD group. CONCLUSIONS: Both VEGF and LEP play roles in the pathophisiological process of CHD. VEGF and LEP are associated with the development of heart failure in children with ACHD.


Subject(s)
Heart Defects, Congenital/blood , Leptin/blood , Vascular Endothelial Growth Factor A/blood , Body Mass Index , Child , Child, Preschool , Female , Hemoglobins/analysis , Humans , Infant , Male , Oxygen/blood
10.
Zhongguo Dang Dai Er Ke Za Zhi ; 11(6): 429-32, 2009 Jun.
Article in Chinese | MEDLINE | ID: mdl-19558803

ABSTRACT

OBJECTIVE: To study the values of brain natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in the evaluation of cardiac function in children with congenital heart disease (CHD). METHODS: Seventy-one children with CHD were classified to two groups: congestive heart failure (CHF) (n=23 ) and non-CHF (n=48). Thirty-five age-matched normal children were used as the control group. Plasma BNP content was measured using a microparticle enzyme immunoassay (MEIA) on the AxSYM. Plasma NT-proBNP content was measured using an automated electrochemiluminescence immunoassay on a Roche Modular Analytics E170 analyzer. Echocardiographic parameters, including left ventricular end diastolic dimension index (LVEDDI) and left ventricular ejection fraction (LVEF), were measured. RESULTS: Plasma BNP and NT-proBNP contents in the CHF group were significantly higher than those in the non-CHF group (P<0.01). The non-CHF group had higher plasma BNP and NT-proBNP contents than the control group (P<0.01). LogBNP and LogNT-proBNP values were negatively correlated with the LVEF in the CHF group (r=-0.64, r=-0.67 respectively, P<0.01), and they were positively correlated with the LVEDDI (r=0.58, r=0.76 respectively, P<0.01). In the non-CHF group, LogBNP and LogNT-proBNP values were not correlated with the LVEF, but a positive correlation was found between the LogNT-proBNP value and the LVEDDI (r=0.35, P<0.05). Using plasma BNP content > or =149.8 pg/mL and NT-proBNP content > or =820.1 pg/mL as cut-off values for diagnosing CHF respectively, the sensitivities were 87.0 % and 91.3% respectively, the specificities were 91.7% and 97.9% respectively, and the areas under the ROC curves were 0.935 and 0.987 respectively. CONCLUSIONS: Both BNP and NT-proBNP can be useful in assessment of cardiac function and diagnosis of CHF in children with CHD. NT-proBNP appears to be more sensitive and specific in the diagnosis of CHF than BNP.


Subject(s)
Heart Defects, Congenital/physiopathology , Heart Failure/diagnosis , Heart/physiopathology , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Child , Child, Preschool , Diastole , Female , Heart Defects, Congenital/blood , Humans , Infant , Male , Ventricular Function, Left
11.
Nan Fang Yi Ke Da Xue Xue Bao ; 27(11): 1762-3, 2007 Nov.
Article in Chinese | MEDLINE | ID: mdl-18024309

ABSTRACT

OBJECTIVE: To investigate the effect of plasma homocysteic acid (HCA) reduction on serum C-reactive protein (CRP) level in children with Kawasaki disease (KD). METHODS: Seventy-six children with KD were divided into 2 equal groups for treatment with aspirin and IVIG, or with vitamin B6 and folic acid besides in addition to aspirin and IVIG. Serum CRP level was tested before and after the treatments, and plasma HCA level was also measured after the treatments. RESULTS: Serum CRP level was comparable between the two groups before the treatment, but significantly reduced after vitamin B6 and folic acid treatment (7.56-/+2.94 mg/L vs 12.23-/+4.16 mg/L, P<0.05). Additional vitamin B6 and folic acid treatment significantly lowered plasma HCA level (4.56-/+1.14 micromol/L vs 7.79-/+1.79 micromol/L, P<0.05), and correlation analysis demonstrated a positive correlation between plasma HCA and serum CRP levels (r=0.697, P<0.01). CONCLUSION: Lowering plasma HCA can decrease serum CRP in children with KD to enhance the therapeutic effect.


Subject(s)
Aspirin/therapeutic use , C-Reactive Protein/analysis , Homocysteine/analogs & derivatives , Immunoglobulins, Intravenous/therapeutic use , Mucocutaneous Lymph Node Syndrome/drug therapy , Child , Child, Preschool , Female , Folic Acid/therapeutic use , Homocysteine/blood , Humans , Infant , Male , Mucocutaneous Lymph Node Syndrome/blood , Vitamin B 6/therapeutic use
12.
Zhonghua Er Ke Za Zhi ; 45(12): 893-7, 2007 Dec.
Article in Chinese | MEDLINE | ID: mdl-18339274

ABSTRACT

OBJECTIVE: To investigate the role of heme oxygenase-1 (HO-1) and its catalyst carbon monoxide (CO) in the development of myocardial damage and the effects of zinc protoporphyrin IX (ZnPPIX), an inhibitor of HO-1 on myocardium of mice with acute viral myocarditis. METHODS: A total of 112 inbred male Balb/C mice 4 - 6 weeks of age were divided randomly into 3 groups: the control group (C group, n = 32), the viral myocarditis group (V group, n = 40) and ZnPPIX group (Z group, n = 40). The Z and V groups were inoculated intraperitoneally (i.p.) with 0.1 ml of 10(-4.36) tissue culture infectious dose 50% (TCID(50))/ml Coxsackie virus B3 (CVB(3)) to produce viral myocarditis model on day 0, C group was injected i.p. with virus-free 1640 culture culture medium 0.1 ml at the same time, then operation was done as follows: the mice of group C and group V were injected i.p. with 0.1 ml NS each day. The mice of group Z were injected i.p. with 40 micromol per kilogram of body weight ZnPPIX (HO-1 inhibitor) qod. Eight mice of each group were sacrificed on days 4, 8, 15 and 21, respectively. The blood specimens were collected by taking out the eyeballs to test for the content of carboxyhemoglobin (COHb) using spectrophotometry and cardiac troponin I (cTnI) using chemiluminescent immunoassay. The hearts tissue slides were also stained by immunohistochemistry (IHC) for HO-1 and in situ hybridization (ISH) for HO-1 mRNA. The histological and ultrastructural changes were observed under light and electron microscopes. RESULTS: (1) The histopathological changes of myocardial cells: in the V and Z groups myocardial inflammatory cells infiltration reached the peak on day 8, the Z group histopathological scores were significantly lower than those in V group on day 8 (2.40 +/- 0.31 vs. 1.73 +/- 0.24, P < 0.01) and on day 15 (1.78 +/- 0.29 vs. 1.43 +/- 0.23, P < 0.05). No inflammation was present in group C. (2) The changes of serum cTnI level in both V and Z groups were significantly higher than those in C group on day 4, 8 and 15 (P < 0.01). The level in Z group was significantly lower than that in V group on day 4 [(6.074 +/- 1.475) ng/ml vs (7.911 +/- 1.225) ng/ml, P < 0.05] and day 8 [(0.821 +/- 0.294) ng/ml vs (1.480 +/- 0.454) ng/ml, P < 0.05]. (3) The changes of blood COHb level: compared with V group, in Z group the COHb level was lower on day 4 (P < 0.05) and day 15 (P < 0.01) after CVB(3) inoculation. Surprisingly, in Z group COHb level elevated suddenly on day 8 and showed conspicuously higher than that of V group (P < 0.01). (4) The result of HO-1 IHC staining: in both V and Z group myocardial cells had positive expression, while C group did not. (5) The results of HO-1 ISH were similar to those of HO-1 IHC, the A values of group Z was significantly lower than that of group V on day 4, 15 and 21(P < 0.01), but on day 8 it was higher than that of group C (P < 0.05). CONCLUSION: HO-1 inhibitor, ZnPP not only could inhibit HO-1 overexpression but also could induce HO-1 expression temporarily and protect against myocardial injury at the early stage of acute viral myocarditis.


Subject(s)
Heme Oxygenase-1/antagonists & inhibitors , Myocarditis/pathology , Myocardium/ultrastructure , Protoporphyrins/pharmacology , Virus Diseases/metabolism , Animals , Male , Mice , Mice, Inbred BALB C , Myocarditis/enzymology , Myocarditis/metabolism , Myocarditis/virology , Myocardium/pathology , Virus Diseases/pathology
13.
Zhonghua Shao Shang Za Zhi ; 21(1): 40-2, 2005 Feb.
Article in Chinese | MEDLINE | ID: mdl-15796845

ABSTRACT

OBJECTIVE: To compare the effects of different kind of methods in the management of hydrofluoric acid burn in early postburn stage in rabbits. METHODS: Thirty-three rabbits were inflicted with burn by 55% of hydrofluoric acid covering 5% TBSA, and were randomly divided into 3 groups, i.e. A (n = 13, with 5 ml.kg(-1).h(-1)of isotonic saline intravenous infusion), B (n = 10, with isotonic saline and 50 g/L of calcium gluconate infusion in dose of 20 mg/kg at different time points), and C (n = 10, with the same treatment as B group, and with excision of burn wound at 0.5 post burn hour) groups. The serum levels of fluorine and calcium were determined before and after various postburn hours, and the mortality rate was statistically analyzed. RESULTS: (1) The serum level of fluorine in A (8.37 +/- 2.62 mg/L) and B (8.59 +/- 2.25 mg/L) groups reached the peak value at 1 postburn hour (PBH), which was 107 times higher than that before the burn injury. The serum level of fluorine in B group was significantly lower than that in A group at 24 PBH (P < 0.05), while that in C group declined to (6.20 +/- 0.23) mg/L, which was obviously lower than that in A and B groups (P < 0.01). (2) The serum calcium level declined after burns, reaching the lowest level at 8 to 12 PBH. and began to increase at 24 PBH. Compared with normal calcium value, the serum level of calcium in A, B and C groups declined to as much as 46%, 32% and 26%, respectively. Statistically significant difference was found between C and B groups (P < 0.01). (3) The mortality rate in the three groups within 72 PBH were 30.8%, 12.5% and 0.0%, respectively. CONCLUSION: Early removal of burn area and calcium supplementation could help quickly decrease blood fluorine, reverse the fatal hypocalcemia and the multiple systemic toxic injury in rabbits inflicted with hydrofluoric acid injury.


Subject(s)
Burns, Chemical/drug therapy , Burns, Chemical/surgery , Elective Surgical Procedures , Animals , Calcium/blood , Calcium Gluconate/therapeutic use , Disease Models, Animal , Fluorine/blood , Hydrofluoric Acid/adverse effects , Rabbits , Random Allocation , Skin Transplantation , Wound Healing
SELECTION OF CITATIONS
SEARCH DETAIL
...